Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. NVAX
NVAX logo

NVAX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NVAX News

Novavax Stock Rises 6% as Activist Investor Shah Capital Plans to Oppose Company's Executive Pay and Board Candidates

Apr 08 2026moomoo

Activist Investor Pressures Novavax Board Ahead of Annual Meeting

Apr 08 2026seekingalpha

Shah Capital Increases Stake in Novavax and Demands Management Changes

Apr 08 2026stocktwits

SHAH CAPITAL CALLS ON NOVAVAX TO REDEEM $225 MILLION CONVERTIBLE BOND AND/OR INITIATE A BUYBACK OF 10-20 MILLION SHARES

Apr 08 2026moomoo

Novavax and Datadog Options Trading Volume Surges

Apr 06 2026NASDAQ.COM

Investors Should Exercise Caution with Low-Priced Stocks

Mar 27 2026Yahoo Finance

BioNTech Announces Earnings, But That's Not the Reason for the 17% Drop in Stock Price.

Mar 10 2026Barron's

FDA Vaccine and Biotech Chief Resigns Amid Industry Criticism

Mar 06 2026CNBC

Novavax Q4 2025 Financial Results Analysis

Feb 27 2026Benzinga

Top Stock Picks: Satellite Communications Firm Poised for Growth

Feb 27 2026NASDAQ.COM

Novavax Q4 Revenue Surges 67% Amid Strategic Shift

Feb 27 2026stocktwits

Novavax to Participate in Upcoming Investor Conferences

Feb 26 2026PRnewswire

Novavax to Participate in Upcoming Investor Conferences

Feb 26 2026Newsfilter

Novavax Q4 2025 Earnings Call Highlights

Feb 26 2026seekingalpha

Novavax Exceeds Expectations in 2025 Financial Results

Feb 26 2026Benzinga

Novavax Executive Expresses Optimism About Moderna's Advancements in Flu Vaccine Development

Feb 26 2026moomoo